Bioelectronica Closes $16 Million Funding from China Investors

Bioelectronica of Reno, Nevada closed a $16 million Series A investment from two China investors, Proxima Ventures and Co-win Ventures, to support its novel drug discovery/development platform. Hypercell® is a single cell sorting platform that uses computer vision, data science and lensless imaging to enable single cell sorting assays with high throughput. Bioelectronica offers CRO services from novel assay development to scalable electrofluidics. The company believes its platform speeds up development and lowers costs. More details.... Share this with colleagues: // //